Investigation of antiviral properties of new formulations of Panavir in the treatment of experimental herpes virus infection in mice
Kushch, A.A.; Galegov, G.A.; Klimova, R.R.; Kozlov, A.I.; Litvin, A.A.
Antibiotiki i Khimioterapiia 53(7-8): 31-34
2008
ISSN/ISBN: 0235-2990 PMID: 19227121 Document Number: 621061
Protective action of Panavir was studied in the treatment of experimental herpes virus infection on albino mice. It was shown, that intravenous and rectal Panavir formulations were able to increase survival of the experimental animals (decreased lethality) infected by HSV-1.
Document emailed within 1 workday
Related Documents
Danielescu, G.; Botnariuc, I.; Cajal, N. 1985: Investigation of humoral and cell-mediated immunity aspects in mice with experimental latent herpes infection Virologie 36(2): 85-94Rajcáni, J. 1971: Experimental infection of mice with Herpes simplex virus Bratislavske Lekarske Listy 56(4): 416-426
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Yoosook, C.; Chantratita, W.; Rimdusit, P. 1989: Recovery frequencies of herpes simplex virus types 1 and 2 from symptomatic and asymptomatic genital herpes cases and antiviral sensitivities of isolates Journal of the Medical Association of Thailand 72(10): 572-576
Galegov, G.A.; Litvin, A.A. 2007: Panavir, as a broad spectrum antiviral agent Antibiotiki i Khimioterapiia 52(9-10): 45-49
Malolina, E.A.; Kulibin, A.I.; Tiulenev, I.A.; Kushch, A.A. 2013: Destructive changes in the mice testes in retrograde infection with herpes simplex virus Urologiia 4: 55-59
Nash, A.A.; Phelan, J.; Wildy, P. 1981: Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response Journal of Immunology 126(4): 1260-1262
Munk, K.; Schwaier, A.; Darai, G. 1978: Experimental infection of tupaias with herpes simplex virus types 1 and 2 Iarc Scientific Publications 1978(24 Part 2): 789-793
Kirchner, H.; Kochen, M.; Munk, K.; Hirt, H.M.; Mergenhagen, S.E.; Rosenstreich, D.L. 1978: Differences in susceptibility to herpes simplex virus infection of inbred strains of mice Iarc Scientific Publications 1978(24 Part 2): 783-788
Morahan, P.S.; Breinig, M.C.; McGeorge, M.B. 1978: Immune responses to vaginal or systemic infection of mice with herpes simplex virus type 2 Iarc Scientific Publications 1978(24 Part 2): 759-763
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264
Choudhury, S.; Choudhury, T. 1983: The effect of herpes simplex virus type 2 infection on the genital tract of the female mice--a virological and cytopathological study Indian Journal of Cancer 20(5): 221-226
Kohl, S.; Loo, L.S. 1982: Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity Journal of Immunology 129(1): 370-376
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Postic, B.; Horvath, J.A.; Talwani, R. 2003: Antiviral treatment of human immunodeficiency virus infection: update for 2003 Journal of the South Carolina Medical Association 99(6): 148-153
Ikemoto, K.; Pollard, R.B.; Fukumoto, T.; Morimatsu, M.; Suzuki, F. 1995: Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1 Journal of Immunology 155(3): 1326-1333
Fernández-Yunquera, A.; Rincón, D.; Salcedo, M.; Bañares, R. 2013: Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 26(3): 189-192
Huldt, G.; Gard, S. 1971: Experimental infection of newborn mice with toxoplasma and Moloney virus Acta Pathologica et Microbiologica Scandinavica. Section B: Microbiology and Immunology 79(3): 441